Piper Sandler on Medtronic, Inc. (MDT): 'RDN Survey Indicates Momentum'
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien reiterated a Neutral rating and $105.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
